HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies.

Abstract
Oleocanthal, a phenolic component of extra-virgin olive oil, has been recently linked to reduced risk of Alzheimer's disease (AD), a neurodegenerative disease that is characterized by accumulation of β-amyloid (Aβ) and tau proteins in the brain. However, the mechanism by which oleocanthal exerts its neuroprotective effect is still incompletely understood. Here, we provide in vitro and in vivo evidence for the potential of oleocanthal to enhance Aβ clearance from the brain via up-regulation of P-glycoprotein (P-gp) and LDL lipoprotein receptor related protein-1 (LRP1), major Aβ transport proteins, at the blood-brain barrier (BBB). Results from in vitro and in vivo studies demonstrated similar and consistent pattern of oleocanthal in controlling Aβ levels. In cultured mice brain endothelial cells, oleocanthal treatment increased P-gp and LRP1 expression and activity. Brain efflux index (BEI%) studies of (125)I-Aβ40 showed that administration of oleocanthal extracted from extra-virgin olive oil to C57BL/6 wild-type mice enhanced (125)I-Aβ40 clearance from the brain and increased the BEI% from 62.0 ± 3.0% for control mice to 79.9 ± 1.6% for oleocanthal treated mice. Increased P-gp and LRP1 expression in the brain microvessels and inhibition studies confirmed the role of up-regulation of these proteins in enhancing (125)I-Aβ40 clearance after oleocanthal treatment. Furthermore, our results demonstrated significant increase in (125)I-Aβ40 degradation as a result of the up-regulation of Aβ degrading enzymes following oleocanthal treatment. In conclusion, these findings provide experimental support that potential reduced risk of AD associated with extra-virgin olive oil could be mediated by enhancement of Aβ clearance from the brain.
AuthorsAlaa H Abuznait, Hisham Qosa, Belnaser A Busnena, Khalid A El Sayed, Amal Kaddoumi
JournalACS chemical neuroscience (ACS Chem Neurosci) Vol. 4 Issue 6 Pg. 973-82 (Jun 19 2013) ISSN: 1948-7193 [Electronic] United States
PMID23414128 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Aldehydes
  • Amyloid beta-Peptides
  • Cyclopentane Monoterpenes
  • Neuroprotective Agents
  • Olive Oil
  • Phenols
  • Plant Oils
  • oleocanthal
Topics
  • Aldehydes (chemistry, pharmacology, therapeutic use)
  • Alzheimer Disease (metabolism, prevention & control)
  • Amyloid beta-Peptides (metabolism)
  • Animals
  • Cells, Cultured
  • Cyclopentane Monoterpenes
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microvessels (drug effects, metabolism)
  • Neuroprotective Agents (chemistry, pharmacology, therapeutic use)
  • Olive Oil
  • Phenols (chemistry, pharmacology, therapeutic use)
  • Plant Oils (chemistry, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: